Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
138 participants
OBSERVATIONAL
2023-06-03
2023-12-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypotension; defined as a 30% reduction in SBP or a 20% reduction in MAP, or an absolute SBP below 90 mm Hg and MAP below 65 mm Hg within 3 minutes of induction of general anesthesia.Intravenous (iv) noradrenaline and/or iv crystalloid will be used in the treatment of hypotension.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound-guided carotid artery flow time measurement
Ultrasound-guided corrected carotid artery flow time will be measured before anestesia induction.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing elective surgery under general anesthesia
Exclusion Criteria
* Systolic blood pressure \> 180 mmHg
* Diastolic blood pressure \> 110 mmHg
* \< 65 years old
* Carotid artery stenosis \> 50%
* ASA \> 3
* Left ventricle ejection fraction \< 40%
* Severe peripheral vascular disease
* Implanted pacemacer
* Autonomic nervous system disorders
* Heart valve disease
* Chronic kidney disease
* Emergency surgery
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cukurova University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
mediha turktan
associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cukurova University
Adana, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Carotid cFT
Identifier Type: -
Identifier Source: org_study_id